HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wanzhen Xu Selected Research

Wanzhen Xu Research Topics

Disease

4Neoplasms (Cancer)
01/2024 - 01/2017
2Glioma (Gliomas)
01/2024 - 01/2022
2Glioblastoma (Glioblastoma Multiforme)
01/2017 - 01/2017
1Neoplasm Metastasis (Metastasis)
01/2024
1Inflammation (Inflammations)
04/2023
1Sepsis (Septicemia)
04/2023
1Sarcopenia
04/2023
1Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2021
1Subdural Hematoma (Subdural Hemorrhage)
02/2021
1Hematoma
02/2021
1Astrocytoma (Pilocytic Astrocytoma)
01/2017

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2022
1Cholinergic ReceptorsIBA
01/2024
1Interleukin-6 (Interleukin 6)IBA
01/2024
1Messenger RNA (mRNA)IBA
01/2024
1RNA (Ribonucleic Acid)IBA
01/2024
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2024
1sulforaphaneIBA
04/2023
1LipopolysaccharidesIBA
04/2023
1Toll-Like Receptor 4IBA
04/2023
1InflammasomesIBA
04/2023
1ChemokinesIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Chemokine ReceptorsIBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Aurora Kinase AIBA
01/2017
1N-phthaloylglutamic acidIBA
01/2017

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2024 - 01/2017
1Immunotherapy
01/2024
1Craniotomy
02/2021